Three-Dimensional Culture Modelling Reveals Divergent Mycobacterium tuberculosis Virulence and Antimicrobial Treatment Response
Cellular Microbiology · 03.05.2024 · 2024 · 1-17
DOI: 10.1155/2024/6458900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Microbiology, erschienen am 03.05.2024. Verfasst von Magdalena K. Bielecka und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Imperial BRC, NAMRIP, Medical Research Council.
Abstract (Originalsprache)
Tuberculosis (TB) remains a persistent epidemic, and the emergence of drug-resistant Mycobacterium tuberculosis (Mtb) presents a global healthcare threat. While some new agents have been successfully introduced, innovative technologies to evaluate emerging anti-TB compounds are required to inform transformative approaches. Mtb is an obligate human pathogen, and consequently utilizing models that are consistent with human disease is likely to be critical. We have developed a human 3-dimensional (3-D) cell culture model that reflects human disease gene expression patterns and causes Mtb to become pyrazinamide sensitive in vitro. Here, we identify key differences in virulence between the standard laboratory strain, Mtb H37Rv, and clinical isolates. We demonstrate that Mtb H37Rv is attenuated in the 3-D system, more susceptible to antibiotics and hyperinflammatory compared to clinical isolates. Prolonged in vitro culture of a clinical strain leads to attenuation. We then characterise antibiotic sensitivity of multi-drug-resistant Mtb within the 3-D model and define relative bactericidal activity. Finally, we demonstrate that verapamil increases efficacy of bedaquiline and delamanid antibiotic therapy. Taken together, our findings suggest that studying virulent clinical strains in an advanced cell culture system is a powerful adjunct to established methodologies to evaluate new interventions for TB.
Förderung
- NIHR Imperial BRC
- NAMRIP
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- UK Antimicrobial Resistance Cross Council Initiative
Zitieren
APA
Bielecka, M. K., Tezera, L. B., Konstantinopoulou, E., Casali, N., Katsamenis, O. L., Gonzalo, X., Drobniewski, F., & Elkington, P. T. (2024). Three-Dimensional Culture Modelling Reveals Divergent Mycobacterium tuberculosis Virulence and Antimicrobial Treatment Response. Cellular Microbiology, 2024, 1-17. https://doi.org/10.1155/2024/6458900
Vancouver
Bielecka MK, Tezera LB, Konstantinopoulou E, Casali N, Katsamenis OL, Gonzalo X, et al. Three-Dimensional Culture Modelling Reveals Divergent Mycobacterium tuberculosis Virulence and Antimicrobial Treatment Response. Cellular Microbiology. 2024;2024:1-17. doi:10.1155/2024/6458900
BibTeX
@article{Bielecka2024,
author = {Bielecka, Magdalena K. and Tezera, Liku B. and Konstantinopoulou, Elena and Casali, Nicola and Katsamenis, Orestis L. and Gonzalo, Ximena and Drobniewski, Francis and Elkington, Paul T.},
title = {Three-Dimensional Culture Modelling Reveals Divergent Mycobacterium tuberculosis Virulence and Antimicrobial Treatment Response},
journal = {Cellular Microbiology},
year = {2024},
volume = {2024},
pages = {1--17},
doi = {10.1155/2024/6458900}
}
EUVIMED